Found 17 matching trials
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults PHASE1 H7N9 avian influenza (AI) viruses have caused a recent outbreak of severe r...
Show More Location
University of Rochester Medical Center
Learn More & Join Trial
Optimizing Impact of Manual Therapy on Lumbar Spinal Stenosis NA Lumbar spinal stenosis, a common condition in older adults, can cause pain ...
Show More Location
Orlando VA Medical Center
Learn More & Join Trial
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery PHASE1 This is a Phase I, single-arm, open-label, dose-escalation study in patient...
Show More Location
Multiple Locations
Learn More & Join Trial
IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost PHASE1 This study seeks to determine the safety and immunogenicity of a series of ...
Show More Location
Department of Clinical Research, USAMRIID
Learn More & Join Trial
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants PHASE2 This study will assess the safety, reactogenicity and immunogenicity of two...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines PHASE1 A phase 1/2, open-label clinical trial in individuals, 18 years of age and ...
Show More Location
The Hope Clinic of Emory University
Learn More & Join Trial
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults PHASE1 The purpose of this study is to evaluate the safety of and immune response ...
Show More Location
Rockville Vaccine Assessment Clinic (RVAC)
Learn More & Join Trial
Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults. PHASE1 VIDO has developed a vaccine called COVAC-2.
The COVAC-2 study vaccine con...
Show More Location
Manna Research (Burlington North)
Learn More & Join Trial
Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers PHASE3 The purpose of the MEQ00073 study is to describe the immunogenicity and saf...
Show More Status
Active Not Recruiting
Location
Investigational Site Number : 2460009
Learn More & Join Trial
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo PHASE3 The purpose of this study is the evaluation of the safety and immunogenicit...
Show More Location
Multiple Locations
Learn More & Join Trial